Literature DB >> 29801418

Rare-Variant Studies to Complement Genome-Wide Association Studies.

A Sazonovs1, J C Barrett1.   

Abstract

Genome-wide association studies (GWASs) have revolutionized human disease genetics by discovering tens of thousands of associations between common variants and complex diseases. In parallel, huge technological advances in DNA sequencing have made it possible to measure and analyze rare variation in populations. This review considers these two stories and how they have come together. We first review the history of GWASs and sequencing. We then consider how to understand the biological mechanisms that drive signals of strong association in the absence of rare-variant studies. We describe how rare-variant studies complement these approaches and highlight both data generation and statistical challenges in their interpretation. Finally, we consider how certain special study designs, such as those for families and isolated populations, fit in this paradigm.

Entities:  

Keywords:  GWAS; fine mapping; rare variants

Mesh:

Year:  2018        PMID: 29801418     DOI: 10.1146/annurev-genom-083117-021641

Source DB:  PubMed          Journal:  Annu Rev Genomics Hum Genet        ISSN: 1527-8204            Impact factor:   8.929


  12 in total

1.  Extent to which array genotyping and imputation with large reference panels approximate deep whole-genome sequencing.

Authors:  Sarah C Hanks; Lukas Forer; Sebastian Schönherr; Jonathon LeFaive; Taylor Martins; Ryan Welch; Sarah A Gagliano Taliun; David Braff; Jill M Johnsen; Eimear E Kenny; Barbara A Konkle; Markku Laakso; Ruth F J Loos; Steven McCarroll; Carlos Pato; Michele T Pato; Albert V Smith; Michael Boehnke; Laura J Scott; Christian Fuchsberger
Journal:  Am J Hum Genet       Date:  2022-08-17       Impact factor: 11.043

2.  Exploring Impact of Rare Variation in Systemic Lupus Erythematosus by a Genome Wide Imputation Approach.

Authors:  Manuel Martínez-Bueno; Marta E Alarcón-Riquelme
Journal:  Front Immunol       Date:  2019-02-26       Impact factor: 7.561

3.  TFEB Gene Promoter Variants Effect on Gene Expression in Acute Myocardial Infarction.

Authors:  Jie Zhang; Yexin Zhang; Xiaohui He; Shuai Wang; Shuchao Pang; Bo Yan
Journal:  Front Cell Dev Biol       Date:  2021-02-25

Review 4.  Emerging roles of rare and low-frequency genetic variants in type 1 diabetes mellitus.

Authors:  Haipeng Pang; Ying Xia; Shuoming Luo; Gan Huang; Xia Li; Zhiguo Xie; Zhiguang Zhou
Journal:  J Med Genet       Date:  2021-03-22       Impact factor: 6.318

5.  Inflammatory Bowel Disease: A Personalized Approach.

Authors:  Anastasia Konidari; David Dickens; Munir Pirmohamed
Journal:  Front Pediatr       Date:  2021-02-11       Impact factor: 3.418

6.  Identification of putative causal loci in whole-genome sequencing data via knockoff statistics.

Authors:  Zihuai He; Linxi Liu; Chen Wang; Yann Le Guen; Justin Lee; Stephanie Gogarten; Fred Lu; Stephen Montgomery; Hua Tang; Edwin K Silverman; Michael H Cho; Michael Greicius; Iuliana Ionita-Laza
Journal:  Nat Commun       Date:  2021-05-25       Impact factor: 17.694

7.  The population frequency of human mitochondrial DNA variants is highly dependent upon mutational bias.

Authors:  Cory D Dunn
Journal:  Biol Open       Date:  2021-10-28       Impact factor: 2.422

8.  Identification of recurrent genetic patterns from targeted sequencing panels with advanced data science: a case-study on sporadic and genetic neurodegenerative diseases.

Authors:  G Castellani; S Capellari; M Tarozzi; A Bartoletti-Stella; D Dall'Olio; T Matteuzzi; S Baiardi; P Parchi
Journal:  BMC Med Genomics       Date:  2022-02-10       Impact factor: 3.063

9.  Presumed COL4A3/COL4A4 Missense/Synonymous Variants Induce Aberrant Splicing.

Authors:  Haiyue Deng; Yanqin Zhang; Jie Ding; Fang Wang
Journal:  Front Med (Lausanne)       Date:  2022-03-21

Review 10.  The Role of Mitochondrial DNA Mutations in Cardiovascular Diseases.

Authors:  Siarhei A Dabravolski; Victoria A Khotina; Vasily N Sukhorukov; Vladislav A Kalmykov; Liudmila M Mikhaleva; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2022-01-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.